This approach has been design ed to provide adequate analgesia while minimizing exposure to adverse events
Background : Laparoscopic cholecystectomy has advantages over the open procedure for postoperative pain .
However , a systematic review of postoperative pain management in this procedure has not been conducted .
Intraperitoneal bupivacaine for analgesia after laparoscopic cholecystectomy
Background The effects of intraperitoneal administration of bupivacaine on  pain after laparoscopic cholecystectomy were studied in a prospect i ve , double‐blind , r and omised trial . Methods : Eighty ASA 1 and 2 patients were r and omly assigned to one of two groups . Immediately after pneumoperi‐toneum was obtained patients in group 1 were given 15 ml of 0.5 % bupivacaine injected under direct vision into the hepato‐diaphragmatic space , near and above the hepato‐duodenal ligament and above the gallbladder . At the end of operation another 15 ml of bupivacaine was injected . Patients in group 2 were given 15 ml of 0.9 % saline solution in a similar fashion . Postoperative pain was assessed using a visual analogue scale ( VAS 100 mm ) at 0.5,4 , 8,12 and 24 h after surgery . Analgesic consumption was also recorded
This approach has been design ed to provide adequate analgesia while minimizing exposure to adverse events
Background : Laparoscopic cholecystectomy has advantages over the open procedure for postoperative pain .
However , a systematic review of postoperative pain management in this procedure has not been conducted .